Indicateurs
1 Consultations de la notice
- Titre
- Outlining the statistical analysis of longitudinal ctDNA assays to determine minimal residual disease in patients with pancreatic ductal adenocarcinoma: the GUIDE.MRD project
- Créateurs - sans rôle
- Brune De Dreuille - Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid - SpainEvangelina López De Maturana - Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid - SpainClaus Lindbjerg Andersen - Aarhus University Hospital, Aarhus, DenmarkEd Schuuring - University Medical Center Groningen, Groningen, HollandEllen Heitzer - Medical University of Graz, Graz, Steiermark, AustriaLidewij Vat - The Synergist, Brussels, Brussels Hoofdstedelijk Gewest, BelgiumMark Rogers - LGC, London, United KingdomRiccardo Bertini - Innovation Acta, SIENA, Toscana, ItalyEstevan Kiernan - Illumina, San Diego, California, United StatesEphrem Chin - Revvity, Boston, Massachusetts, United StatesJ. Carl Barrett - AstraZeneca, Boston, Massachusetts, United StatesJoshua Kapp - Amgen, Los Angeles, California, United StatesGilles Erb - Roche, Basel, Basel-Stadt, SwitzerlandMarco Gerling - Karolinska Institutet, Stockholm, Stockholms Lan, SwedenMartin Reck - Lungen Clinic, Airway Research Center North, German Center for Lung Research, Großhansdorf, Hamburg, GermanySvenja Schneegans-Murano - Institute of Tumor Biology, University Hospital Hamburg-Eppendorf, Hamburg, GermanyAnn-Kristin Afflerbach - Institute of Tumor Biology, University Hospital Hamburg-Eppendorf, Hamburg, GermanyLina Bergmann - Institute of Tumor Biology, University Hospital Hamburg-Eppendorf, Hamburg, GermanyThomas Bardol - Université de MontpellierMatthias Löhr - Karolinska Institutet, Stockholm, Stockholms Lan, SwedenPaul Hofman - Institute for Research on Cancer and Aging, Nice, Provence-Alpes-Cote d Azur, FranceJeroen Hiltermann - University Medical Center Groningen, Groningen, HollandMads Heilskov Rasmussen - Aarhus University Hospital, Aarhus, DenmarkCatherine Alix-Panabières - Laboratory of Rare Circulating Human Cells, CREEC/CANECEV, MIVEGEC (CREES), Université de Montpellier, CNRS, IRD, Montpellier, Ile-de-France, FranceDaniel J. Smit - Institute of Tumor Biology, University Hospital Hamburg-Eppendorf, Hamburg, GermanyMohan Bolisetty - Bristol Myers Squibb, Princeton, NJ, Philadelphia, Pennsylvania, United StatesMaria Karasarides - Bristol Myers Squibb, Princeton, NJ, Philadelphia, Pennsylvania, United StatesNúria Malats - Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid - SpainKlaus Pantel - Institute of Tumor Biology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
- Détails de publication
- Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], Vol.24, pp.e114-e114
- Éditeur
- Elsevier B.V
- Identifiants
- 99159093309311
- Unité académique
- Maladies Infectieuses et Vecteurs : Ecologie, Génétique, Evolution et Contrôle - MIVEGEC
- Langue
- English
- Type de ressource
- Journal article